Scholar Rock Presents NEW BASE Data from the SRK-015 TOPAZ Trial

The biomarker data from the TOPAZ Phase 2 proof-of-concept trial evaluating SRK-015 for the treatment of patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA).

Clinical Trials
NCT03921528

Read more